Key Points CRISPR Therapeutics has a couple of pipeline candidates with massive opportunities. The company has already shown that it can get approval for its gene-editing medicines. Despte sizable upside potential for the stock, investors should proceed with caution. 10 stocks we like better than CRISPR Therapeutics › Becoming a millionaire through stock investing is possible, but it requires patience, discipline, and the acumen to make informed investment choices. Not every company can generate ...